Jeffrey G. Wiese, MD, is a Professor of Medicine with Tenure and an academic hospitalist. Dr. Wiese has previously served as Chief of the Charity Medical Service, Director of the Tulane Internal Medicine Residency Program and Senior Associate Dean for Graduate Medical Education at the Tulane. Dr. Wiese has devoted much of his career to teaching and educational research, logging over 23,000 hours of teaching time, and winning over 50 teaching awards. Although he stopped accepting teaching awards in 2008, his, most notable awards include: a six-time winner of Tulane’s Attending of the Year Award, Society of Hospital Medicine’ Education Award, ACGME’s Parker Palmer Courage to Teach Award, the AAMC’s Robert J. Glaser Distinguished Teacher Award, the ACP’s Walter J. McDonald Award, and the Society of General Internal Medicine’s Mid-Career Mentorship Award.
Dr. Wiese has written over 100 articles, books, or book chapters and has made over 300 presentations to national and international audiences. He has mentored over 200 student and resident presentations at national meetings. He previously served on the ABIM Council, and as the Chair of the ABIM Internal Medicine Board. He has also been a board member for the Society of Hospital Medicine, The ACP Board of Regents, The Association of Program Directors in Internal Medicine, and The Association of Subspecialty Professors. During his tenure as president of the Society of Hospital Medicine, he was instrumental in enacting the Academic Hospitalist Academy and the Quality and Safety Educators Academy. As the chair of the ABIM hospital medicine committee, he has been instrumental in developing the Focused-Practice Hospital Medicine Maintenance of Certification pathway.
Dr. Wiese has been actively involved in redesigning graduate medical education throughout his innovations such as the “academic half day curriculum” and the “4+1 residency model of training” have become widely adopted by residency programs across the US. He was the primary investigator for two HRSA grants, providing over three million dollars in support for improving transitions-of-care for vulnerable patient populations.
